1. Home
  2. LXRX vs FATN Comparison

LXRX vs FATN Comparison

Compare LXRX & FATN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FATN
  • Stock Information
  • Founded
  • LXRX 1995
  • FATN 1989
  • Country
  • LXRX United States
  • FATN United States
  • Employees
  • LXRX N/A
  • FATN N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FATN
  • Sector
  • LXRX Health Care
  • FATN
  • Exchange
  • LXRX Nasdaq
  • FATN NYSE
  • Market Cap
  • LXRX 124.4M
  • FATN 111.3M
  • IPO Year
  • LXRX 2000
  • FATN 2025
  • Fundamental
  • Price
  • LXRX $0.51
  • FATN $12.43
  • Analyst Decision
  • LXRX Buy
  • FATN
  • Analyst Count
  • LXRX 4
  • FATN 0
  • Target Price
  • LXRX $3.67
  • FATN N/A
  • AVG Volume (30 Days)
  • LXRX 32.2M
  • FATN 2.6M
  • Earning Date
  • LXRX 05-01-2025
  • FATN 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • FATN N/A
  • EPS Growth
  • LXRX N/A
  • FATN 56.77
  • EPS
  • LXRX N/A
  • FATN 0.37
  • Revenue
  • LXRX $31,081,000.00
  • FATN $17,876,645.00
  • Revenue This Year
  • LXRX N/A
  • FATN N/A
  • Revenue Next Year
  • LXRX $63.36
  • FATN N/A
  • P/E Ratio
  • LXRX N/A
  • FATN $33.90
  • Revenue Growth
  • LXRX 2481.48
  • FATN 13.17
  • 52 Week Low
  • LXRX $0.28
  • FATN $5.60
  • 52 Week High
  • LXRX $2.45
  • FATN $23.27
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 53.30
  • FATN N/A
  • Support Level
  • LXRX $0.48
  • FATN N/A
  • Resistance Level
  • LXRX $0.60
  • FATN N/A
  • Average True Range (ATR)
  • LXRX 0.09
  • FATN 0.00
  • MACD
  • LXRX 0.01
  • FATN 0.00
  • Stochastic Oscillator
  • LXRX 42.86
  • FATN 0.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About FATN FATPIPE INC

Fatpipe Inc is a pioneer in enterprise-class, application-aware, secure SD-WAN solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. It is engaged in delivering principal enterprise-class networking software technology. The company is dedicated to continually improving the way organizations connect, ensuring their networks are secure, reliable, and supporting their continued success. Its commitment lies in empowering its customers with a seamless and dependable connectivity infrastructure that safeguards their critical data and fosters business continuity. Further, the company's goal is to ensure its customers have unparalleled insights into their network operations.

Share on Social Networks: